241 related articles for article (PubMed ID: 22572545)
21. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Montemurro M; Cioffi A; Dômont J; Rutkowski P; Roth AD; von Moos R; Inauen R; Toulmonde M; Burkhard RO; Knuesli C; Bauer S; Cassier P; Schwarb H; Le Cesne A; Koeberle D; Bärtschi D; Dietrich D; Biaggi C; Prior J; Leyvraz S
Cancer; 2018 Apr; 124(7):1449-1454. PubMed ID: 29315500
[TBL] [Abstract][Full Text] [Related]
22. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
23. The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.
Betz M; Kopp HG; Spira D; Claussen CD; Horger M
Acta Radiol; 2013 Sep; 54(7):711-21. PubMed ID: 23761542
[TBL] [Abstract][Full Text] [Related]
24. [Importance of PET for surgery of gastrointestinal stromal tumors].
Ronellenfitsch U; Wängler B; Niedermoser S; Dimitrakopoulou-Strauss A; Hohenberger P
Chirurg; 2014 Jun; 85(6):493-9. PubMed ID: 24823996
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
26. Esophageal gastrointestinal stromal tumor: report of 7 patients.
Shinagare AB; Zukotynski KA; Krajewski KM; Jagannathan JP; Butrynski J; Hornick JL; Ramaiya NH
Cancer Imaging; 2012 Apr; 12(1):100-8. PubMed ID: 22542728
[TBL] [Abstract][Full Text] [Related]
27. [Imaging of neuroendocrine tumors of the gastrointestinal tract : Value of (hybrid) imaging diagnostics in radiology].
Ebner R; Rübenthaler J; Ricke J; Sheikh GT; Unterrainer LM; Auernhammer CJ; Spitzweg C; Brendel M; Schmid-Tannwald C; Cyran CC
Radiologie (Heidelb); 2024 Jul; 64(7):553-558. PubMed ID: 38713221
[TBL] [Abstract][Full Text] [Related]
28. Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours.
Kim JS; Kim HJ; Park SH; Lee JS; Kim AY; Ha HK
Eur Radiol; 2017 Jun; 27(6):2583-2590. PubMed ID: 27761711
[TBL] [Abstract][Full Text] [Related]
29. Role of F-18-FDG-PET/CT in restaging of patients affected by gastrointestinal stromal tumours (GIST).
Bertagna F; Bosio G; Orlando E; Biasiotto G; Giubbini R
Nucl Med Rev Cent East Eur; 2010; 13(2):76-80. PubMed ID: 21598231
[TBL] [Abstract][Full Text] [Related]
30. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
31. Increasing the accuracy of volume and ADC delineation for heterogeneous tumor on diffusion-weighted MRI: correlation with PET/CT.
Gong NJ; Wong CS; Chu YC; Guo H; Huang B; Chan Q
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):407-13. PubMed ID: 23958150
[TBL] [Abstract][Full Text] [Related]
32. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
34. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
[TBL] [Abstract][Full Text] [Related]
35. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
Orcurto V; Denys A; Voelter V; Schalenbourg A; Schnyder P; Zografos L; Leyvraz S; Delaloye AB; Prior JO
Melanoma Res; 2012 Feb; 22(1):63-9. PubMed ID: 22027909
[TBL] [Abstract][Full Text] [Related]
36. Current and Potential Applications of Artificial Intelligence in Gastrointestinal Stromal Tumor Imaging.
Yang CW; Liu XJ; Liu SY; Wan S; Ye Z; Song B
Contrast Media Mol Imaging; 2020; 2020():6058159. PubMed ID: 33304203
[TBL] [Abstract][Full Text] [Related]
37. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
38. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
[TBL] [Abstract][Full Text] [Related]
39. Value of CT in the diagnosis and follow-up of gastrointestinal stromal tumors.
Gong JS; Zuo M; Yang P; Zang D; Zhang Y; Xia L; Xu JM; Wang X; Yu X
Clin Imaging; 2008; 32(3):172-7. PubMed ID: 18502343
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors.
Ren C; Wang S; Zhang S
Cancer Imaging; 2020 Jan; 20(1):5. PubMed ID: 31931874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
